RLMD
RELMADA THERAPEU (RLMD)
NASDAQ
$3.67+$0.005 (+0.14%)
Price as of Oct 02, 2026 6:09 PM EDT
  • $390.4M
    Market Cap
  • 37.59%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
N/A
10.64%
11.2M
+11.2M (+100.00%)
Jun 30, 2026
JUPITER TOPCO LLC
10.64%
11.2M
+11.2M (+100.00%)
Jun 30, 2026
JANUS HENDERSON GROUP PLC
10.55%
11.1M
+3.8M (+34.29%)
Mar 31, 2026
BLACKROCK, INC.
7.08%
7.4M
+6.1M (+82.64%)
Jun 30, 2026
SQUADRON CAPITAL MANAGEMENT LLC
7.01%
7.3M
-1.1M (-15.30%)
Jun 30, 2026
VR ADVISER, LLC
6.53%
6.8M
+2.0M (+29.23%)
Jun 30, 2026
SPRUCE STREET CAPITAL LP
6.09%
6.4M
+129,214 (+2.02%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions481.9M (87.45%)
  • Mutual Funds63.9M (11.60%)
  • Insiders5.2M (0.95%)
  • Other0 (0.00%)

Insider Transactions

  • 0.95% (5.2M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $11.2M
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
TRAVERSA SERGIO
Chief Executive Officer
Buy
Sep 10, 2026
$410,000.00
100,000
$4.10
1.5M
TRAVERSA SERGIO
Chief Executive Officer
Buy
Sep 09, 2026
$418,000.00
100,000
$4.18
1.4M